LUVIRA
Pharmaceuticals, namely, combination therapeutic compositions for the treatment of immunological diseases, hyperproliferative diseases, cancer, metabolic diseases, neurodegenerative diseases, infectious diseases, viral diseases, autosomal-recessive genetic diseases, and degenerative muscular diseases
Abandoned · June 7, 2007 · 77200579 ·